News
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
13h
Wellbeing Magazine on MSNPreventing the winter illsA holistic cold and flu prevention plan using vitamins, herbs, lifestyle tips and immune support for a healthy, resilient winter. The post Preventing the winter ills appeared first on WellBeing ...
Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
The preservative is in a small share of flu shots and has been studied for decades. Experts say it’s safe — despite Kennedy’s long opposition.
The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.
TeamSense reports unplanned absences cost American businesses $600B annually, highlighting patterns to help manage ...
When the seasonal flu strikes, most people expect the familiar lineup of fever, aches and congestion. But for many patients, dizziness emerges as an ...
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the ...
A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...
RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...
Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results